Guidant back on track in US AAA (abdominal aortic aneurysms) implants market
This article was originally published in Clinica
Executive Summary
Guidant expects to resume implanting its Ancure endovascular grafts this week in US patients with abdominal aortic aneurysms (AAA). The company suspended production and announced a recall of its inventory on March 16 after a series of device malfunctions and adverse events highlighted potential problems in deployment of the device.